Comparison of two basal insulin analogs (insulin lispro protamine suspension and insulin determir) in basal-bolus therapy for patients with type 1 diabetes.
Phase of Trial: Phase III
Latest Information Update: 05 Oct 2016
At a glance
- Drugs Insulin detemir; Insulin neutral protamine lispro/insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 25 Sep 2008 The actual number of patients enrolled was 388 according to ClinicalTrials.gov record.
- 25 Sep 2008 Status changed from active, no longer recruiting to completed as reported in the ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History